Vascular smooth muscle cell activation by C-reactive protein.

[1]  U. Ikeda,et al.  C-Reactive protein augments inducible nitric oxide synthase expression in cytokine-stimulated cardiac myocytes. , 2002, Cardiovascular research.

[2]  Y. Hattori,et al.  Vascular Smooth Muscle Cell Activation by Glycated Albumin (Amadori Adducts) , 2002, Hypertension.

[3]  V. Hombach,et al.  C-Reactive Protein–Mediated Low Density Lipoprotein Uptake by Macrophages: Implications for Atherosclerosis , 2001, Circulation.

[4]  Andrew C. Li,et al.  Peroxisome proliferator–activated receptor γ ligands inhibit development of atherosclerosis in LDL receptor–deficient mice , 2000 .

[5]  Y. Hattori,et al.  The effects of thiazolidinediones on vascular smooth muscle cell activation by angiotensin II. , 2000, Biochemical and biophysical research communications.

[6]  V. Pasceri,et al.  Modulation of vascular inflammation in vitro and in vivo by peroxisome proliferator-activated receptor-gamma activators. , 2000, Circulation.

[7]  J. Egido,et al.  Atorvastatin reduces NF-kappaB activation and chemokine expression in vascular smooth muscle cells and mononuclear cells. , 1999, Atherosclerosis.

[8]  W. Hsueh,et al.  Peroxisome proliferator-activated receptor activators target human endothelial cells to inhibit leukocyte-endothelial cell interaction. , 1999, Arteriosclerosis, thrombosis, and vascular biology.

[9]  M. Pfeffer,et al.  Long-Term Effects of Pravastatin on Plasma Concentration of C-reactive Protein , 1999 .

[10]  P. Libby,et al.  PPARα Activators Inhibit Cytokine-Induced Vascular Cell Adhesion Molecule-1 Expression in Human Endothelial Cells , 1999 .

[11]  Y. Hattori,et al.  Glycated serum albumin-induced nitric oxide production in vascular smooth muscle cells by nuclear factor kappaB-dependent transcriptional activation of inducible nitric oxide synthase. , 1999, Biochemical and biophysical research communications.

[12]  A. Döring,et al.  C-Reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study, 1984 to 1992. , 1999, Circulation.

[13]  J. Egido,et al.  HMG-CoA reductase inhibition by atorvastatin reduces neointimal inflammation in a rabbit model of atherosclerosis. , 1998, Journal of the American College of Cardiology.

[14]  T. Edgington.  More cellular signals for atherogenesis? , 1998, Circulation.

[15]  Ratnam,et al.  The regulation of superoxide generation and nitric oxide synthesis by C‐reactive protein , 1998, Immunology.

[16]  R. Ross,et al.  Atherosclerosis is an Inflammatory Disease , 1998 .

[17]  P. Libby,et al.  The Nuclear Factor κ-B Signaling Pathway Participates in Dysregulation of Vascular Smooth Muscle Cells in Vitroand in Human Atherosclerosis* , 1997, The Journal of Biological Chemistry.

[18]  P. Ridker,et al.  Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. , 1997, The New England journal of medicine.

[19]  J P Cooke,et al.  Nitric oxide synthase: role in the genesis of vascular disease. , 1997, Annual review of medicine.

[20]  P. Baeuerle,et al.  Role of nuclear factor‐kappa B in atherogenesis , 1997, Experimental physiology.

[21]  F. Marcucci,et al.  Effect of partially modified retro‐inverso analogues derived from C‐reactive protein on the induction of nitric oxide synthesis in peritoneal macrophages , 1997, British journal of pharmacology.

[22]  S. Thompson,et al.  Production of C-reactive protein and risk of coronary events in stable and unstable angina , 1997, The Lancet.

[23]  S. Moncada,et al.  Molecular mechanisms and therapeutic strategies related to nitric oxide , 1995, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[24]  A. Rebuzzi,et al.  The prognostic value of C-reactive protein and serum amyloid a protein in severe unstable angina. , 1994, The New England journal of medicine.

[25]  W. A. Bradley,et al.  Superoxide and peroxynitrite in atherosclerosis. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[26]  Balaraman Kalyanaraman,et al.  Peroxynitrite modification of low‐density lipoprotein leads to recognition by the macrophage scavenger receptor , 1993, FEBS letters.

[27]  E. Leonard,et al.  Detection of monocyte chemoattractant protein-1 in human atherosclerotic lesions by an anti-monocyte chemoattractant protein-1 monoclonal antibody. , 1993, Human pathology.

[28]  S. Gross,et al.  Tetrahydrobiopterin synthesis. An absolute requirement for cytokine-induced nitric oxide generation by vascular smooth muscle. , 1992, The Journal of biological chemistry.

[29]  J S Beckman,et al.  Peroxynitrite formation from macrophage-derived nitric oxide. , 1992, Archives of biochemistry and biophysics.

[30]  S. Snyder,et al.  Nitric oxide, a novel biologic messenger , 1992, Cell.

[31]  C. Nathan,et al.  Nitric oxide as a secretory product of mammalian cells , 1992, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[32]  S. Akira,et al.  IL‐6 and NF‐IL6 in Acute‐Phase Response and Viral Infection , 1992, Immunological reviews.

[33]  S. Coughlin,et al.  Monocyte chemoattractant protein-1 in human atheromatous plaques. , 1991, The Journal of clinical investigation.

[34]  P. Libby,et al.  Proliferating or interleukin 1-activated human vascular smooth muscle cells secrete copious interleukin 6. , 1990, The Journal of clinical investigation.

[35]  B. Freeman,et al.  Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[36]  W. Schaffner,et al.  Rapid detection of octamer binding proteins with 'mini-extracts', prepared from a small number of cells. , 1989, Nucleic acids research.

[37]  P. Chomczyński,et al.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. , 1987, Analytical biochemistry.

[38]  M. Wilson,et al.  The simultaneous generation of superoxide and nitric oxide can initiate lipid peroxidation in human low density lipoprotein. , 1992, Free radical research communications.

[39]  P. Libby,et al.  Involvement of the immune system in human atherogenesis: current knowledge and unanswered questions. , 1991, Laboratory investigation; a journal of technical methods and pathology.

[40]  A. Feinstein,et al.  Isolation and characterization of C-reactive protein and serum amyloid P component in the rat. , 1982, Immunology.

[41]  R. Ross,et al.  The smooth muscle cell in culture. , 1979, Physiological reviews.

[42]  Peter Søgaard,et al.  Electromechanical Mapping for Detection of Myocardial Viability in Patients With Ischemic Cardiomyopathy , 2001, Circulation.